Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCS-05 in acute optic neuritis
NCT04762017Phase 2Completed
- Sponsor
- Oculis
- Start
- Feb 2021
- Primary completion
- Sep 2024
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of privosegtor in optic neuritis (ON), sponsored by Oculis. Started Feb 2021; status: completed.
02
Drugs
privosegtor
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on NCT04762017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04762017.